Evidence map›Paper›PMID 16299533›Full record

ReviewOncogene2005

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.

Deepika Ahuja, M Teresa Sáenz-Robles, James M Pipas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 314 papers.

0numbers the graph read from it
0cells of the map it votes in
314citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

314 citing papers in PubMed, 553 citations in OpenAlex.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Chiropteran (Animals : an open access journal from MDPI · 2026
    Article
  6. Article
  7. Article
  8. TCF1bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Gas1-Mediated Suppression of Hepatoblastoma Tumorigenesis.The American journal of pathology · 2025
    Article
  18. Article
  19. Article
  20. Article

254 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Deepika AhujaDepartment of Biological Sciences, University of Pittsburgh, PA 15260, USA.
M Teresa Sáenz-Robles
James M Pipas
University of Pittsburgh · US

Funding

Expression of Simian Virus 40 T antigens in IntestineR01CA098956 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PIPAS, JAMES M · 2003 to 2013
$3.2M
SV40 T ANTIGEN--ROLE IN VIRUS GROWTH AND TRANSFORMATIONR01CA040586 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PIPAS, JAMES M · 1985 to 2010
$2.7M
GENETIC ANALYSIS OF THE SV40 LARGE TUMOR ANTIGENR37CA040586 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PIPAS, JAMES M · 1988 to 1995
–
NCI NIH HHS CA098956NCI NIH HHS CA40586
6 · The paper itself

Abstract

DNA tumor viruses such as simian virus 40 (SV40) express dominant acting oncoproteins that exert their effects by associating with key cellular targets and altering the signaling pathways they govern. Thus, tumor viruses have proved to be invaluable aids in identifying proteins that participate in tumorigenesis, and in understanding the molecular basis for the transformed phenotype. The roles played by the SV40-encoded 708 amino-acid large T antigen (T antigen), and 174 amino acid small T antigen (t antigen), in transformation have been examined extensively. These studies have firmly established that large T antigen's inhibition of the p53 and Rb-family of tumor suppressors and small T antigen's action on the pp2A phosphatase, are important for SV40-induced transformation. It is not yet clear if the Rb, p53 and pp2A proteins are the only targets through which SV40 transforms cells, or whether additional targets await discovery. Finally, expression of SV40 oncoproteins in transgenic mice results in effects ranging from hyperplasia to invasive carcinoma accompanied by metastasis, depending on the tissue in which they are expressed. Thus, the consequences of SV40 action on these targets depend on the cell type being studied. The identification of additional cellular targets important for transformation, and understanding the molecular basis for the cell type-specific action of the viral T antigens are two important areas through which SV40 will continue to contribute to our understanding of cancer.

Indexed as

Cell Transformation, NeoplasticGenes, p53Genes, RetinoblastomaAnimalsAntigens, Polyomavirus TransformingGene Expression RegulationHyperplasiaMiceMice, TransgenicNeoplasm InvasivenessNeoplasm MetastasisOncogene ProteinsPhenotypeAntigens, Polyomavirus TransformingOncogene Proteins

Identifiers

PMID16299533
OpenAlexW1979051583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.